Scholarlink

Purpose of Review <p>This review explores the relationship between sexual dysfunction (SD) and neurogenic lower urinary tract dysfunction (NLUTD) in women, focusing on diagnostic challenges, evaluation methods, and treatment strategies.</p> Recent Findings <p>SD in women with NLUTD is multifactorial, influenced by medical comorbidities and psychosocial factors. Advances in hormonal therapies, pharmacologic agents, and treatments for concomitant urinary incontinence (chemodenervation and neurostimulation) show promise for treatment. However, gaps remain in validated screening tools, physician training, and standardized treatment protocols, creating barriers to care.</p> Summary <p>Managing SD in women with NLUTD requires a multidisciplinary approach. While current treatments demonstrate potential, standardized guidelines and evidence-based screening tools are lacking. Future efforts should focus on developing universal protocols and innovative therapies to improve quality of life and clinical outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sexual Dysfunction as it Intersects with Neurogenic Lower Urinary Tract Dysfunction in Women

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月2日

查看全文
  • Akash Sharma,
  • Tracy Cheung,
  • Nitya Abraham

摘要

Purpose of Review

This review explores the relationship between sexual dysfunction (SD) and neurogenic lower urinary tract dysfunction (NLUTD) in women, focusing on diagnostic challenges, evaluation methods, and treatment strategies.

Recent Findings

SD in women with NLUTD is multifactorial, influenced by medical comorbidities and psychosocial factors. Advances in hormonal therapies, pharmacologic agents, and treatments for concomitant urinary incontinence (chemodenervation and neurostimulation) show promise for treatment. However, gaps remain in validated screening tools, physician training, and standardized treatment protocols, creating barriers to care.

Summary

Managing SD in women with NLUTD requires a multidisciplinary approach. While current treatments demonstrate potential, standardized guidelines and evidence-based screening tools are lacking. Future efforts should focus on developing universal protocols and innovative therapies to improve quality of life and clinical outcomes.